Tuberculosis is one of the world's health problems, especially in developing countries.
Treatment regimen with multiple first-line anti-tuberculosis drugs (ATD) such as Isoniazid …

Tuberculosis is one of world health problem, especially in developing countries. Treatment
regimen with multiple first-line anti-tuberculosis drugs (ATD) such as Isoniazid, Rifampicin …

Tuberculosis is a potentially communicable disease that can infect any organ in the body
such as bones, kidney, intestine but primarily involves lung parenchyma (Pulmonary …

Isoniazid, Rifampin and Pyrazinamide are first line antituberculosis medication. Among them
isoniazid and pyrazinamide inhibit mycolic acid synthesis and rifampicin inhibit RNA …

Drug-induced liver injury (DILI) accounts for 20–40% of cases of fulminant hepatic failure.
Antitubercular therapy (ATT) may cause hepatotoxicity which can range from transient …

Background: As per the World Health Organization Global Tuberculosis (TB) Report 2019,
there were an estimated 10.0 million new TB cases worldwide in 2018, with India (27%) …

Hepatic involvement in extra-pulmonary tuberculosis (TB) is rare, even in the endemic area.
It has a high mortality rate as it can easily be misdiagnosed due to its rarity and non-specific …

Background: Tuberculosis (TB) is a very common droplet infection especially in the northern
areas. If untreated, the disease may be fatal within 5 years in more than half of cases. To …

Background: Tuberculosis, also called as TB, is a highly contagious bacterial infection and
can be found nearly anywhere in the body, but lungs are the most common site of infection …